Top Biotechnology companies in Denmark by Gross Profit

This ranking features the top 15 Biotechnology companies in Denmark ranked by Gross Profit, totalling a Gross Profit of USD 7.17 B, for January 15, 2025.
#
Name
Gross Profit
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 2.41 B
Dec. 31, 2023 USD 216.88 1.28%

Denmark

2
USD 2.28 B
Dec. 31, 2023 USD 5.46 0.56%

Denmark

3
USD 1.44 B
Dec. 31, 2023 USD 54.16 -1.39%

Denmark

4
USD 670.05 M
Dec. 31, 2023 USD 26.62 -0.36%

Denmark

5
USD 245.39 M
Dec. 31, 2023 USD 131.57 -1.84%

Denmark

6
USD 52.93 M
June 30, 2024 USD 70.50 0.61%

Denmark

7
USD 47.90 M
Dec. 31, 2023 USD 95.84 0.08%

Denmark

8
USD 17.01 M
Dec. 31, 2023 USD 91.43 -1.85%

Denmark

9
USD 2.99 M
Dec. 31, 2023 USD 0.20 -2.77%

Denmark

10
USD 1.16 M
Dec. 31, 2023 USD 0.57 1.47%

Denmark

11
USD 859.26 K
Dec. 31, 2023 USD 1.93 -6.19%

Denmark

12
USD 335.88 K
Dec. 31, 2023 USD 2.17 5.88%

Denmark

13
USD 62.61 K
Dec. 31, 2023 USD 3.98 0.01%

Denmark

14
USD -3.47 K
Dec. 31, 2023 USD 0.64 1.38%

Denmark

15
USD -111.86 K
Dec. 31, 2023 USD 0.63 -3.68%

Denmark

Frequently Asked Questions
  • Which Biotechnology company in Denmark has the highest Gross Profit ?

    The Biotechnology company in Denmark with the highest Gross Profit is Genmab A/S (Copenhagen Stock Exchange: GMAB.CO) at USD 2.41 B.

  • Which Biotechnology company in Denmark has the lowest Gross Profit ?

    The Biotechnology company in Denmark with the lowest Gross Profit is BactiQuant A/S (Copenhagen Stock Exchange: BACTIQ.CO) at USD -111.86 K.